Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04721860 · ClinicalTrials.gov registry record · NA
Optimizing Training in Severe Post-Stroke Walking Impairment
A NA study, sponsored by University of Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT04721860: Completed NA study, sponsored by University of Cincinnati.
NCT04721860 is a NA study that has completed, run by University of Cincinnati. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04721860, a NA study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
Difficulty walking is common after a stroke. Although physical rehabilitation helps a little with the improvement of walking ability, recovery is usually incomplete. The purpose of this study is to explore how two different treadmill training approaches influence walking speed, symmetry, and balance in people with chronic severe stroke-related walking impairment. The two approaches involve either forward or backwards treadmill training. This study will look at changes in walking performance and balance, before and after training. This study may lead to more efficient methods for improving walking performance and balance after stroke.
Primary Outcome
Two 10MWT trials (using a stop-watch) are averaged and documented in meters/second.
Interventions
- BEHAVIORAL Backward Locomotion Treadmill Training (BLTT)
- BEHAVIORAL Forward Locomotion Treadmill Training (FLTT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2020-10-15 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
What the finished NCT04721860 record still lists
NCT04721860 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Backward Locomotion Treadmill Training (BLTT) is the first listed.
NCT04721860 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04721860 about?
NCT04721860 is a clinical study titled "Optimizing Training in Severe Post-Stroke Walking Impairment". Difficulty walking is common after a stroke. Although physical rehabilitation helps a little with the improvement of walking ability, recovery is usually incomplete. The purpose of this study is to explore how two different treadmill training approaches influence walking speed, symmetry, and balance...
What is the current status of trial NCT04721860?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2020-10-15. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT04721860?
The interventions under investigation include: Backward Locomotion Treadmill Training (BLTT) (BEHAVIORAL), Forward Locomotion Treadmill Training (FLTT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04721860?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04721860's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI